PremiumCompany AnnouncementsZiff Davis Reports Positive Earnings with Key Segment Growth Ziff Davis Announces Segment Realignment After Annual Meeting Ziff Davis Reports Q1 2025 Financial Results PremiumThe FlyZiff Davis downgraded to Neutral from Overweight at JPMorgan Ziff Davis’s Everyday Health Group buys theSkimm Ziff Davis Reports Growth Amid Challenges in 2024 Earnings Call PremiumThe FlyZiff Davis price target lowered to $48 from $61 at Barclays Ziff Davis Reports Q4 2024 Financial Results Ziff Davis reports Q4 EPS $2.58, consensus $2.63